Daiichi Sankyo Co. Ltd. (TYO:4568) is making antibody drug conjugates (ADCs) and other next-generation biopharmaceuticals a pillar for medium- and long-term growth. The Japanese pharmaceutical company has initiated phase 2...
pharmaceuticals
Nippi to Increase Production of Collagen Peptides
Nippi Inc. (TYO:7932) is expanding its collagen peptide production facilities to meet growing demand for the functional material. The company is investing 3.3 billion yen ($31.05 million) in building a...
Interview: Meiji Seika Pharma President Talks Drug Pricing Reform, Business Targets
Meiji Seika Pharma Co. Ltd. is transitioning in more ways than one as of late, not only adjusting to new criteria under Japan’s drug pricing system but also getting ready...
Western Chemical Companies in Japan – Part 13: Lonza
The Chemical Daily recently conducted a round of interviews with the heads of Japanese subsidiaries of Western chemical companies. For this installment, we talked with Tatsuya Naganawa, president & representative director...
Industry Outlook 2018: Pharmaceuticals
In the field of next-generation drugs, there are high hopes for nucleic acid pharmaceuticals. Launched by Biogen Japan Ltd. in August 2017 as a treatment for spinal muscular atrophy (SMA),...
Takeda Pharmaceutical to Form New Joint Venture With PRA in Japan, Restructure Clinical Development
Takeda Pharmaceutical Co. Ltd. (TYO:4502) recently announced a new clinical development approach in Japan that it will run in partnership with PRA Health Sciences Inc., a U.S.-based contract research organization...
Fushimi Pharmaceutical Develops Easy Method for Sugar Chain Bonding
Fushimi Pharmaceutical Co. Ltd. has developed a simple reaction by which chemical compounds with low and high molecular weights can be bonded to sugar chains. Until now, a simple, easy...
Japan’s Agriculture Ministry to Create New Industry Using Transgenic Silkworms
Japan’s Ministry of Agriculture, Forestry and Fisheries (MAFF) is launching a five-year project starting in fiscal 2017 to create new industries through sericulture innovation. The project’s aim is to harness...
Mitsui Chemicals Moves Into In Vitro Diagnostic Pharmaceuticals
Mitsui Chemicals Inc. (TYO:4183) is entering the business of in vitro pharmaceuticals with plans to launch a research exam kit in March 2017 that can identify in three-to-five hours the...
Nagase to Distribute Nucleic Acid Drugs Globally
Nagase & Co. Ltd. (TYO:8012) announced on Jan. 24 that it will enter the nucleic acid pharmaceuticals business after signing an exclusive distribution contract with Shikoku Kakusan Kagaku, a manufacturer...
PhoenixBio to Supply Human Liver Cell-Bearing Mice to Overseas Drug Firms
PhoenixBio Co. Ltd. (TYO:6190) has begun U.S. marketing of experimental PXB mice with human liver cells. Many large pharmaceuticals manufacturers are conducting experiments on PXB mice at in-house research facilities...
Fujifilm Partners with Major Russian Pharmaceutical Firm
Fujifilm Holdings Corp. (TYO:4901) announced on Dec. 16 that it has agreed with Russian pharmaceuticals manufacturer R-Pharm to enter into a comprehensive business partnership. Established in 2001, Moscow-based R-Pharm operates...
Pharmaceutical Industry Feels Deep Impact With 2016 Drug Pricing Reform
An aspect with huge impact from the 2016 drug pricing system reform has been the provision for exceptional reprising. Implemented in April, the newly adopted system provides for price reductions...
Biotech is Key to Future Drug Development, Says Chugai Pharmaceutical CEO
Chugai Pharmaceutical Co. Ltd. (TYO:4519) is taking on new challenges in the realm of biotech-based drug development. The Chemical Daily had a chance to interview Chugai Pharmaceutical President and CEO...
Junsei Chemical Embarks on Manufacturing of Active Ingredients for Generic Pharmaceuticals
Junsei Chemical Co. Ltd. has entered the market for active ingredients used in generic pharmaceuticals, having begun producing multiple active ingredients at a newly built facility at the firm’s main...
Rion Targets Regenerative Medicine Facilities for Particle Counter Sales
Particle counter manufacturer Rion Co. Ltd. (TYO:6823) is taking aggressive moves in the market for environmental monitoring of regenerative medicine facilities. This is in response to the expansion of the...
Japan Works to Perfect Domestic Biopharma Manufacturing Capabilities
European and U.S. corporations now have an exclusive hold on the manufacturing technologies used in the advanced field of pharmaceuticals that are antibody drugs. Japan, which has virtually no technological...
Central Social Insurance Medical Council Accepts Special Measures for Costly Drugs
In its general meeting on July 27, the Central Social Insurance Medical Council (Chuikyo) accepted special countermeasures proposed by the Ministry of Health, Labour and Welfare for costly medicines. The...
